Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023

SELL
$144.61 - $166.54 $10 Million - $11.5 Million
-69,278 Reduced 95.89%
2,970 $473,000
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $5.89 Million - $7.06 Million
-42,593 Reduced 37.09%
72,248 $11.7 Million
Q3 2022

Nov 01, 2022

SELL
$134.21 - $153.93 $442,893 - $507,969
-3,300 Reduced 2.79%
114,841 $15.4 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $3.46 Million - $4.4 Million
-25,165 Reduced 17.56%
118,141 $18.1 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $291,675 - $361,887
-2,210 Reduced 1.52%
143,306 $23.2 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $1.41 Million - $1.78 Million
-13,099 Reduced 8.26%
145,516 $19.7 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $133,532 - $151,578
-1,255 Reduced 0.79%
158,615 $17.1 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $3.26 Million - $3.63 Million
31,000 Added 24.06%
159,870 $18 Million
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $3.49 Million - $3.84 Million
34,114 Added 36.0%
128,870 $13.9 Million
Q4 2020

Feb 17, 2021

BUY
$80.49 - $108.67 $1.91 Million - $2.58 Million
23,731 Added 33.41%
94,756 $10.2 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $4.87 Million - $5.71 Million
56,657 Added 394.33%
71,025 $6.22 Million
Q2 2020

Aug 24, 2020

SELL
$73.37 - $98.18 $1.93 Million - $2.58 Million
-26,300 Reduced 64.67%
14,368 $1.41 Million
Q1 2020

May 11, 2020

SELL
$64.5 - $97.79 $145,383 - $220,418
-2,254 Reduced 5.25%
40,668 $3.1 Million
Q4 2019

Feb 05, 2020

BUY
$72.13 - $90.25 $2.84 Million - $3.56 Million
39,422 Added 1126.34%
42,922 $3.8 Million
Q3 2019

Oct 30, 2019

BUY
$62.98 - $75.72 $220,430 - $265,020
3,500 New
3,500 $265,000
Q4 2018

Feb 15, 2019

SELL
$77.85 - $96.01 $66,172 - $81,608
-850 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$88.91 - $98.84 $31,118 - $34,594
350 Added 70.0%
850 $80,000
Q1 2018

Nov 09, 2018

BUY
$92.01 - $123.21 $46,005 - $61,605
500 New
500 $47,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Oak Grove Capital LLC Portfolio

Follow Oak Grove Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Grove Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Grove Capital LLC with notifications on news.